X4 Pharmaceuticals, Inc. drugs

1 result
  • xolremdi - mavorixafor capsule, gelatin coated

    (Mavorixafor)
    X4 Pharmaceuticals, Inc.
    Xolremdi is indicated for patients 12 years and older with WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis) to increase circulating mature neutrophils and lymphocytes.